Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
ARS
2022 FY
Annual report to shareholders
15 May 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Adapthealth Appoints Suzanne Foster As Chief Executive Officer
17 Apr 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Adapthealth Corp. Announces Fourth Quarter and Full-year 2023 Results and Provides Initial 2024 Outlook
27 Feb 24
8-K
Departure of Directors or Certain Officers
27 Dec 23
8-K
Departure of Directors or Certain Officers
22 Nov 23
8-K
Adapthealth Corp. Announces Third Quarter 2023 Results
7 Nov 23
8-K
Departure of Directors or Certain Officers
31 Oct 23
8-K
Other Events
20 Sep 23
8-K
Departure of Directors or Certain Officers
29 Aug 23
8-K
Regulation FD Disclosure
16 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
13 Dec 23
S-8
Registration of securities for employees
6 Aug 21
S-3
Shelf registration
29 Jun 21
S-8
Registration of securities for employees
4 Jun 21
424B5
Prospectus supplement for primary offering
7 Jan 21
424B5
Prospectus supplement for primary offering
4 Jan 21
S-3
Shelf registration
18 Dec 20
424B3
Prospectus supplement
7 Dec 20
424B3
Prospectus supplement
7 Dec 20
424B3
Prospectus supplement
6 Nov 20
Proxies
DEF 14A
Definitive proxy
26 Apr 24
PRE 14A
Preliminary proxy
12 Apr 24
DEFA14A
Additional proxy soliciting materials
10 May 23
DEF 14A
Definitive proxy
1 May 23
DEF 14A
Definitive proxy
29 Apr 22
DEF 14A
Definitive proxy
6 Jul 21
PRE 14A
Preliminary proxy
22 Jun 21
DEF 14A
Definitive proxy
20 Jan 21
PRER14A
Preliminary revised proxy
11 Jan 21
PRE 14A
Preliminary proxy
22 Dec 20
Other
UPLOAD
Letter from SEC
21 Oct 22
CORRESP
Correspondence with SEC
7 Oct 22
UPLOAD
Letter from SEC
27 Sep 22
EFFECT
Notice of effectiveness
19 Jul 21
CORRESP
Correspondence with SEC
14 Jul 21
UPLOAD
Letter from SEC
2 Jul 21
UPLOAD
Letter from SEC
25 Jan 21
CORRESP
Correspondence with SEC
11 Jan 21
UPLOAD
Letter from SEC
7 Jan 21
EFFECT
Notice of effectiveness
31 Dec 20
Ownership
5
RICHARD A BARASCH
8 Apr 24
4
Jason A Clemens
20 Mar 24
4
James E Flynn
12 Mar 24
3
James E Flynn
8 Mar 24
4
RICHARD A BARASCH
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Flynn James E
12 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Shaw Rietkerk
7 Feb 24